Because of the decreased number of CD11b+Gr1+ cells that can successfully inhibit T cell proliferation, we propose that the mechanism driving the decrease in T cells is not related to CD11b+Gr1+ function and may be linked to the increase of VEGF in tumor tissue [32]. The gene discussed is ITGAM; the disease is neoplasm.